Does glutathione support antioxidant defense and phase II detoxification while toxicant exposure increases its demand?

Glutathione (GSH) is the most abundant intracellular low-molecular-weight thiol, serving as a master regulator of cellular redox homeostasis and hepatic biotransformation. Under chemical or environmental stress, maintaining the intracellular pool of GSH is vital for preventing cellular injury.

Antioxidant and detoxification mechanisms

• Redox buffering: GSH acts as an essential cofactor for glutathione peroxidases (GPX1 and GPX4) to reduce hydrogen peroxides and lipid hydroperoxides, directly safeguarding cell membranes from lipid peroxidation and ferroptosis. It also directly scavenges hydroxyl and peroxyl radicals via hydrogen atom transfer.
• Phase II conjugation: Glutathione S-transferases (GSTs) bind GSH to lower its thiol pKa, generating a highly reactive thiolate anion (GS⁻). This nucleophile attacks electrophilic xenobiotics, forming water-soluble conjugates destined for excretion via the mercapturic acid pathway.

Impact of toxicant and mycotoxin exposure

• GSH depletion: Exposure to environmental toxicants and mycotoxins (including aflatoxin B1, ochratoxin A, trichothecenes, and acetaminophen) generates high reactive oxygen species (ROS) loads and directly consumes GSH through GST-mediated conjugation.
• Upregulated synthetic demand: To counter depletion, cells activate the Nrf2 signaling pathway, which transcriptionally upregulates the rate-limiting enzyme glutamate-cysteine ligase (GCL), comprising catalytic (GCLC) and modifier (GCLM) subunits. This adaptive response accelerates de novo GSH synthesis to prevent severe cytotoxicity.

Bottom line

• Toxicant and mycotoxin exposures deplete intracellular glutathione, which serves as a critical antioxidant and Phase II substrate. This depletion triggers adaptive, Nrf2-mediated upregulation of the rate-limiting enzyme glutamate-cysteine ligase to meet the heightened metabolic demand for glutathione synthesis and maintain redox balance.